Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2563709 | Pharmacology & Therapeutics | 2014 | 20 Pages |
Abstract
In recent decades coronary microvascular dysfunction has been increasingly identified as a relevant contributor to several cardiovascular conditions. Indeed, coronary microvascular abnormalities have been recognized in patients suffering acute myocardial infarction, chronic stable angina and cardiomyopathies, and also in patients with hypertension, obesity and diabetes. In this review, we will examine pathophysiological information needed to understand pharmacological approaches to coronary microvascular dysfunction in these different clinical contexts. Well-established drugs and new pharmacological agents, including those for which only preclinical data are available, will be covered in detail.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Giacinta Guarini, Alda Huqi, Doralisa Morrone, Paola Capozza, Giancarlo Todiere, Mario Marzilli,